TARSUS PHARMACEUTICALS, INC. Earnings Per Share, Basic and Diluted
TARSUS PHARMACEUTICALS, INC. (TARS) reported Earnings Per Share, Basic and Diluted of -$4.32 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-31.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-03-31
- TARSUS PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$3.71.
- TARSUS PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2019-09-30 was -$0.28.
- TARSUS PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2020 was -$4.32.
- TARSUS PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2019 was -$1.98.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|
| 2020-12-31 | -$4.32 10-K · filed 2021-03-31 | ||
| 2020-09-30 | -$3.71 10-Q · filed 2020-11-25 | -$5.73 10-Q · filed 2020-11-25 | |
| 2019-12-31 | -$1.98 10-K · filed 2021-03-31 | ||
| 2019-09-30 | -$0.28 10-Q · filed 2020-11-25 | -$1.41 10-Q · filed 2020-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |